Mutations in the TNSALP gene can result in either a complete loss or only 40% of normal alkaline phosphatase activity
This leaves less glutathione available for cosmetic benefits like skin brightening
Incorporating patient-specific factors, including genetic markers, metabolic profiles, and patterns of albuminuria, can facilitate earlier detection, improve prognostic accuracy and enable more precise selection of therapeutic interventions, moving clinical practice towards individualized management strategies [34,35,36,37]
There is interest in using the peptide to induce anabolism in catabolic conditions (e.g
Private Insurance Coverage is highly variable: Most plans cover for diabetes (Ozempic, Mounjaro) Obesity coverage (Wegovy, Zepbound) is inconsistent Many require BMI 30+ or BMI 27+ with comorbidities Prior authorization almost always required Some plans increased BMI thresholds to 32 or 35 in 2024-2025 Tip: If denied, appeals often succeed with documentation of metabolic dysfunction (elevated fasting glucose, insulin resistance, lipid abnormalities)
Going forward, future research should address the following gaps that need to be filled
.png)
